Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease.,Diabetes, Obesity and Metabolism

当前位置： X-MOL 学术 › Diabetes Obes. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease.
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2020-04-01 , DOI: 10.1111/dom.14040
Mohamad Isam Saeed ₁ , Josefin Eklöf ₁ , Imane Achir ₁ , Pradeesh Sivapalan _{1,

2} , Howraman Meteran ₁ , Anders Løkke ₃ , Tor Biering-Sørensen ₄ , Filip Krag Knop _{5,

6,

7,

8} , Jens-Ulrik Staehr Jensen _{1,

6,

9}

Affiliation

To determine the risk of type 2 diabetes onset associated with accumulated inhaled corticosteroids (ICS) dose during the previous year in patients with chronic obstructive pulmonary disease (COPD).

中文翻译：